Genitourinary Cancer,Prostate Cancer Nivolumab + Rucaparib for Treating Patients With mCRPC May 02, 2023
Genitourinary Cancer,Prostate Cancer Improving Outcomes in mCRPC: Cabozantinib and Atezolizumab Combination Therapy May 02, 2023
Genitourinary Cancer,Prostate Cancer Exploring the Efficacy of 177Lu-PSMA-617 in Metastatic Castrate-Resistant Prostate Cancer May 02, 2023
Genitourinary Cancer,Prostate Cancer Rezvilutamide vs Bicalutamide + ADT for Hormone Sensitive Prostate Cancer May 02, 2023
Bladder Cancer,Genitourinary Cancer KEYNOTE-676 Study Shows Improved Efficacy and Safety for Non-Muscle Invasive Bladder Cancer Treatment Apr 20, 2023
Bladder Cancer,Genitourinary Cancer COXEN: Revolutionizing Chemotherapy Treatment for Bladder Cancer Patients Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Oral Infigratinib for Invasive Urothelial Carcinoma with FGFR3 Genetic Alterations: A Promising Therapy Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Targeting Molecular Alterations in Advanced Solid Tumors: My Pathway Study Phase 2A Study Apr 20, 2023